Title : LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease - Ruff_2021_Arterioscler.Thromb.Vasc.Biol__ATVBAHA120315757